Drug Trial Radar · NCT05064202
Unloading in Heart Failure Cardiogenic Shock
Last checked: Nov 19, 2026Latest source record: Aug 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
456
Planned (sponsor's estimate)
Start
Oct 1, 2023
Primary completion
Oct 1, 2027
Study completion Jul 1, 2028
Sponsor
- Lead sponsor
- Amsterdam UMC, location VUmcAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Abiomed Inc.
- First posted
- Oct 1, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to evaluate whether timely and aggressive temporary Mechanical Circulatory Support (tMCS) through the Impella 5.5® in patients with acute decompensated heart failure complicated by cardiogenic shock (ADHF-CS) has the potential to reduce the HF-CS related clinical events compared to the current standard of care.
Conditions
- Cardiogenic Shock
Interventions
Impella 5.5Device
temporary Mechanical Circulatory Support (tMCS)
InotropesDrug
Enoximone, Dobutamine, Dopamine, Milrinone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of all-cause mortality, renal replacement therapy and rehospitalization or urgent visit for heart failure (Efficacy - Primary Combined Clinical Endpoint)Time frame: baseline to 90 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Academical Medical Center (AMC)
Amsterdam, Netherlands
VU University Medical Center (VUMC)
Amsterdam, Netherlands
Univerity Medical Center Groningen (UMCG)
Groningen, Netherlands
Leids Universitair Medisch Centrum (LUMC)
Leiden, Netherlands
University Medical Center Utrecht (UMCU)
Utrecht, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.